Higher than expected rebound for Carl Zeiss Meditec in Q2

Carl Zeiss Meditec has announced better than expected results for the quarter ended March 31 (Q2) as sales jumped by 19 percent year-on-year to €560 million based on preliminary data. The strong growth was driven by Dutch Ophthalmic Research Center (DORC), a business acquired last year and integrated from April ...

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.